$13.22
+0.00 (+0.00%)
Last updated: Jul 15, 2026 04:29
Fundamentals Overview
Cross Country Healthcare, Inc. is near the high of its 52-week range with low valuation, trading relatively flat today.
Valuation low
Intrinsic value (DCF)
+2.7% upside vs price
Risk (Beta)
0.45 — lower vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B · 3M vs S&P 500: +26.3% · 3M vs Healthcare sector: +28.9%
Pressures (Sell):
Sentiment weakening (4 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 5, Hold: 8, Market Perform: 5, Neutral: 5, Outperform: 7.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $13.57; current price is $13.22. That’s a +2.7% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| DCF value (model) | $13.57 (2.7% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.33 |
| P/S (TTM) | 0.43 |
| P/FCF (TTM) | 10.78 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 3.29 |
| Quick Ratio (TTM) | 3.29 |
| Cash Ratio (TTM) | 1.17 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -9.84% |
| Gross margin (TTM) | 19.84% |
| Operating margin (TTM) | -2.08% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for CCRN.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Barrington Research | maintain | Market Perform | Market Perform | 2026-06-08 |
| Truist Securities | maintain | Hold | Hold | 2026-05-11 |
| Benchmark | downgrade | Buy | Hold | 2026-05-08 |
| Wedbush | downgrade | Outperform | Neutral | 2026-05-07 |
| Wedbush | upgrade | Neutral | Outperform | 2026-03-19 |
| Benchmark | upgrade | Hold | Buy | 2026-03-05 |
| UBS | maintain | Neutral | Neutral | 2025-12-09 |
| Barrington Research | maintain | Market Perform | Market Perform | 2025-06-17 |
| UBS | maintain | Neutral | Neutral | 2025-05-13 |
| Barrington Research | maintain | Market Perform | Market Perform | 2025-03-14 |
| JMP Securities | maintain | Market Perform | Market Perform | 2025-02-06 |
| Barrington Research | downgrade | Outperform | Market Perform | 2024-12-10 |
| Truist Securities | maintain | Hold | Hold | 2024-12-05 |
| Benchmark | maintain | Buy | Buy | 2024-11-07 |
| Truist Securities | maintain | Hold | Hold | 2024-10-21 |
| Barrington Research | maintain | Outperform | Outperform | 2024-08-08 |
| Truist Securities | maintain | Hold | Hold | 2024-08-01 |
| Barrington Research | maintain | Outperform | Outperform | 2024-05-06 |
| Benchmark | maintain | Buy | Buy | 2024-05-02 |
| Barrington Research | maintain | Outperform | Outperform | 2024-02-27 |
| Benchmark | maintain | Buy | Buy | 2024-02-22 |
| Truist Securities | maintain | Hold | Hold | 2024-02-22 |
| Barrington Research | maintain | Outperform | Outperform | 2023-11-29 |
| Jefferies | downgrade | Buy | Hold | 2023-11-03 |
| Truist Securities | maintain | Hold | Hold | 2023-11-03 |
| Jefferies | maintain | Buy | Buy | 2023-10-05 |
| Barrington Research | maintain | Outperform | Outperform | 2023-08-14 |
| Credit Suisse | maintain | Neutral | Neutral | 2023-08-08 |
| Barrington Research | maintain | Outperform | Outperform | 2023-06-01 |
| Credit Suisse | maintain | Neutral | Neutral | 2023-05-05 |